Collection Sites Announces Agreement with Sandor Development to Launch Testing Sites at 65 Big Boxstore Locations Across the U.S. - Seite 2

Nachrichtenquelle: globenewswire
21.10.2020, 13:30  |  191   |   |   

QuestCap’s/Collection Sites’ real estate broker, Ryan Zickler of Zickler Associates LLC, also headquartered in Indiana, presented the concept to Sandor as a means to provide retail shoppers a convenient location for COVID testing throughout the US at Sandor properties.  Zickler brokered the transaction and helped facilitate post lease execution logistics between the parties.

The key to flattening the curve is to increase testing.

The new testing centers will offer convenient access to rapid antibody and antigen (pending availability) tests - which take 8-10 minutes to administer and provide results within 24 hours. The sites also offer regular RT-PCR, with results within 24 hours of testing.  All tests can be administered with insurance coverage options. The tests results can be communicated via text or email and can be accompanied with a certificate of good health via a HIPAA-compliant smartphone application.

For more information about the pop-up lab, the available sites and services visit www.testbeforeyougo.com.

About Sandor Development
Sandor is one of the largest privately-held shopping center developers in the nation, owning and operating over 8 million square feet of retail across 25 states. Building on over 55 years of success and with a focus on center revitalization, Sandor has the stability to take a long-term view of property and market success. Sandor has acquired more than $700 million of undeveloped land, existing centers, and single-tenant assets.

About QuestCap Inc.
QuestCap Inc. (NEO:QSC; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, QuestCap offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.

QuestCap has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space.   This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.

QuestCap’s primary focus is the sale of COVID-19 IgG/IgM antibody tests authorized by FDA under an EUA for use by authorized laboratories. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal  www.testbeforeyougo.com. Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.

Seite 2 von 4
Medivolve Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen
Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Collection Sites Announces Agreement with Sandor Development to Launch Testing Sites at 65 Big Boxstore Locations Across the U.S. - Seite 2 TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) - QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce the launch of an agreement between its wholly owned subsidiary, Collection Sites, LLC and Sandor Development Company …

Nachrichten des Autors

Titel
Titel
Titel
Titel